Omega Healthcare Investors, Inc. delivered a strong fourth quarter in 2025, with net income increasing to $172 million and Adjusted FFO per diluted share rising to $0.80. The company made substantial new investments totaling $334 million and repaid $1.27 billion in aggregate debt, contributing to reduced leverage. Full year 2025 results also showed significant growth in net income and AFFO.

Omega Healthcare delivered solid Q3 2025 performance, increasing net income to $185M and adjusted FFO to $243M, while deploying over $150M in new investments and maintaining high occupancy rates.

Omega Healthcare saw increased profitability in Q2 2025 with $140 million in net income and continued its investment momentum with $527 million in new investments.

Omega Healthcare posted solid Q1 2025 results, with notable increases in revenue, net income, and AFFO. The company raised its full-year AFFO guidance, driven by $423M in YTD investments and stronger operator performance.

Omega Healthcare Investors, Inc. reported strong fourth quarter 2024 results with net income of $116 million and Adjusted FFO of $214 million. The company completed $340 million in new investments during the quarter and issued $438 million in equity, while also providing 2025 Adjusted FFO guidance.

Omega Healthcare Investors, Inc. announced its Q3 2024 results, featuring a net income of $115 million, or $0.42 per common share, and adjusted Funds From Operations (FFO) of $203 million, or $0.74 per common share. The company completed $440 million in new investments during the quarter and increased its full-year AFFO guidance to $2.84 to $2.86 per share.

Omega Healthcare Investors reported a net income of $117 million, or $0.45 per common share, for the second quarter of 2024. The company completed $221 million in new investments and increased its full-year AFFO guidance to $2.78-$2.84 per share.

Omega Healthcare Investors reported a net income of $69.3 million, or $0.27 per common share, for Q1 2024, compared to $36.8 million, or $0.15 per common share, for Q1 2023. The company completed $75 million in new investments and repaid $42 million in HUD mortgage loans. Revenues for the quarter totaled $243.3 million, an increase of $25.1 million over the same period in 2023.

Omega Healthcare Investors, Inc. announced its Q4 2023 results, featuring a net income of $57 million, or $0.22 per common share, and adjusted funds from operations (AFFO) of $173 million, or $0.68 per common share. The company completed $249 million in new investments and sold 32 facilities for $324 million, with improving portfolio operating performance.

Omega Healthcare Investors reported a net income of $94 million, or $0.37 per common share, for the quarter ended September 30, 2023. The company completed $106 million in new investments, including real estate acquisitions and loans, and strengthened its balance sheet with a $429 million term loan. Revenues for the quarter totaled $242.0 million, an increase of $2.6 million over the same period in 2022.

Omega Healthcare Investors, Inc. reported a net income of $62 million, or $0.25 per common share, for the second quarter of 2023. The company completed $270 million in new investments and repaid $350 million of senior unsecured notes. While the company's financial performance exceeded expectations, FAD may decline in the third quarter if incremental rents are not received.

Omega Healthcare Investors reported a net income of $37 million, or $0.15 per common share, for the quarter ended March 31, 2023. The company's financial performance was in line with expectations, reflecting the impact of previously disclosed operator restructurings. The company completed $26 million in real estate acquisitions and $233 million in new investments.

Omega Healthcare Investors, Inc. reported a net income of $47 million for Q4 2022, an increase compared to the same period in 2021. However, total revenues decreased due to operator restructurings and asset sales. The company completed new investments and continued to work through operator restructurings.

Omega Healthcare Investors reported a net income of $105.1 million for the quarter ended September 30, 2022, a decrease of $37.8 million compared to the same period in 2021. Revenues totaled $239.4 million, a decrease of $42.2 million over the same period in 2021. The decrease primarily resulted from asset sales, operator restructurings, and no rental income from Agemo Holdings, LLC.

Omega Healthcare Investors reported a net income increase for the second quarter of 2022, but experienced a decrease in revenues and adjusted funds from operations due to asset sales, operator restructurings, and nonpayment of rent from certain operators. The company invested in new loans and projects, repurchased shares, and sold facilities, while also dealing with operator issues and restructurings.

Omega Healthcare Investors reported a net income of $195.2 million for Q1 2022, an increase from $164.4 million in Q1 2021. However, revenues decreased to $249.3 million from $273.8 million year-over-year. The company completed $142 million in new investments and sold Gulf Coast assets for $318 million.

Omega Healthcare Investors, Inc. reported a net income of $34.2 million, or $0.14 per common share, for the quarter ended December 31, 2021. Revenues for the quarter totaled $249.9 million. Portfolio occupancy growth stalled due to a stretched labor market and the Omicron variant, impacting operator profitability.

Omega Healthcare Investors reported a strong third quarter with a net income of $142.8 million and revenue of $281.7 million. The company completed significant real estate investments but faced challenges with rent collection from certain operators, which could impact future financial results.

Omega Healthcare Investors, Inc. reported a positive second quarter with strong Adjusted FFO and FAD, driven by solid rent collections. The company strengthened its balance sheet with a new credit facility and equity issuance. Facility occupancy improved, but operators still rely on government support due to levels remaining below pre-pandemic levels.

Omega Healthcare Investors reported a strong start to 2021, marked by $611 million in new investments, including acquisitions of senior living and skilled nursing facilities. The company also executed significant capital market transactions, issuing $700 million in notes and repurchasing $350 million in existing notes, enhancing its balance sheet and extending debt maturities. Net income for the quarter was $164.4 million, or $0.69 per common share.

Omega Healthcare Investors reported a net income of $63.1 million, or $0.27 per common share, for the quarter ended December 31, 2020. The company completed $98 million in new investments and issued $153 million of equity during the quarter. They also issued $700 million in 3.375% notes due in 2031.

Omega Healthcare Investors reported a net loss of ($93.8) million, or ($0.40) per common share, for the quarter ended September 30, 2020. However, the company's Adjusted Funds From Operations (AFFO) stood at $191.8 million, or $0.82 per common share, showing operational strength. Revenue for the quarter was $119.2 million.

Omega Healthcare Investors reported a net income of $102.0 million, or $0.43 per common share, and revenues of $256.4 million for the quarter ended June 30, 2020. The company completed $50 million in new investments and collected over 99% of contractual rent and mortgage payments.

Omega Healthcare Investors reported a net income of $92.3 million, or $0.39 per common share, and revenues of $253.0 million for the quarter ended March 31, 2020. The company also highlighted its efforts to support operators during the COVID-19 pandemic.

Omega Healthcare Investors, Inc. reported a net income of $61.1 million, or $0.27 per common share, on revenues of $246.7 million for the quarter ended December 31, 2019. The company completed $896 million in new investments during the quarter, including the Encore portfolio acquisition and a joint venture in the U.K. senior housing market. The quarterly dividend was increased by $0.01 to $0.67 per share.